###begin article-title 0
###xml 61 69 <span type="species:ncbi:9606">Children</span>
Serum IL-1beta, IL-2, and IL-6 in Insulin-Dependent Diabetic Children
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 853 854 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 938 939 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1040 1041 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 647 655 <span type="species:ncbi:9606">children</span>
###xml 699 707 <span type="species:ncbi:9606">children</span>
###xml 743 751 <span type="species:ncbi:9606">Children</span>
###xml 822 830 <span type="species:ncbi:9606">patients</span>
###xml 882 890 <span type="species:ncbi:9606">patients</span>
###xml 971 979 <span type="species:ncbi:9606">patients</span>
###xml 1272 1280 <span type="species:ncbi:9606">patients</span>
Insulin-dependent diabetes mellitus (IDDM) is a chronic disease characterized by T-cell-dependent autoimmune destruction of the insulin-producing beta cells in the pancreatic islets of Langerhans, resulting in an absolute lack of insulin. T cells are activated in response to islet-dominant autoantigens, the result being the development of IDDM. Insulin is one of the islet autoantigens responsible for the activation of T-lymphocyte functions, inflammatory cytokine production, and development of IDDM. The aim of this study was to investigate serum concentrations of interleukin (IL)-1beta, IL-2, IL-6, and tumor necrosis factor (TNF)-alpha in children IDDM. The study population consisted of 27 children with IDDM and 25 healthy controls. Children with IDDM were divided into three subgroups: (1) previously diagnosed patients (long standing IDDM) (n : 15), (2) newly diagnosed patients with diabetic ketoacidosis (before treatment) (n : 12), and (3) newly diagnosed patients with diabetic ketoacidosis (after treatment for two weeks) (n : 12). In all stages of diabetes higher levels of IL-1beta and TNF- alpha and lower levels of IL-2 and IL-6 were detected. Our data about elevated serum IL-1beta, TNF- alpha and decreased IL-2, IL-6 levels in newly diagnosed IDDM patients in comparison with longer standing cases supports an activation of systemic inflammatory process during early phases of IDDM which may be indicative of an ongoing beta-cell destruction. Persistence of significant difference between the cases with IDDM monitored for a long time and controls in terms of IL-1beta, IL-2, IL-6, and TNF-alpha supports continuous activation during the late stages of diabetes.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 231 232 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 320 321 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 444 445 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 559 561 553 555 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</chem-struct>
###xml 564 565 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 512 517 <span type="species:ncbi:9606">human</span>
Recent evidence favors primary role of cellular autoimmunity and its humoral mediators in pathogenesis and following IDDM [1]. IDDM is an autoimmune disease with an inflammatory process directed against the beta cells in pancreas [2]. Monocyte and type 1 T-cell-derived cytokines contribute to the pathogenesis of IDDM [3]. Chemokines play a central role in inflammatory processes by regulating leukocyte migration into sites of tissue damage [4]. Cytokines have been proposed as inducers of beta-cell damage in human IDDM via the generation of nitric oxide (NO) [5].
###end p 4
###begin p 5
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 331 332 324 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 454 455 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 462 463 455 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 850 851 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 853 854 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 856 857 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
The autoantigen insulin is responsible for stimulation in vitro of potentially hazardous memory lymphocytes to produce IL-6 and IL-10 [6]. A T helper 1 (TH1) subset of the T cells and their cytokine products (type 1 cytokines: IL-2, interferon (INF)-gamma, and tumour necrosis factor (TNF)-beta) dominate over an immunoregulatory TH2 subset of T cells and their cytokine products (type 2 cytokines: IL-4, IL-5, and IL-13). There is an imbalance between TH1 and TH2 subsets. This allows type 1 cytokines to initiate a cascade of immune-inflammatory processes in the islet, which includes activating macrophages to produce proinflammatory cytokines. The proinflammatory cytokines, IL-1beta, IL-6, and TNF-alpha, have cytotoxic, cytostatic (inhibits insulin synthesis and secretion), or cytocidal actions to pancreatic islets by inducing NO production [4, 6, 7].
###end p 5
###begin p 6
###xml 331 332 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 777 778 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1299 1300 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 833 841 <span type="species:ncbi:9606">patients</span>
###xml 933 941 <span type="species:ncbi:9606">patients</span>
###xml 995 1003 <span type="species:ncbi:9606">patients</span>
###xml 1106 1114 <span type="species:ncbi:9606">patients</span>
###xml 1235 1243 <span type="species:ncbi:9606">patients</span>
Recent reports suggest that the pancreas participates in TNF-alpha production during stress, and that the islets are predominantly responsible for such synthesis. IL-1beta and TNF-alpha are important for the beta-cell lysis in IDDM, while IL-1 receptor antagonist (IL-1ra) is considered protective by blocking the effects of IL-1 [2]. In vitro TNF-alpha and IL-1beta inhibit insulin release from islet beta cells. It appears that the process of autoimmune aggression against beta cells, and its effect on insulin release and glucose homeostasis, is a slow and chronic process. However, the production of these cytokines and consequently the degree of beta-cell destruction, in a genetically susceptible subject, might be enhanced by several factors including viral infections [8]. In some studies performed with newly diagnosed IDDM patients production of IL-1 was found to be increased significantly when compared with chronic IDDM patients and healthy controls. IL-1ra/IL-1 ratio decreased in patients with ND-IDDM and returned to normal in LS-IDDM group. Circulating concentrations of IL-1ra in LS-IDDM patients have increased. Any change in TNF synthesis was not detected. This data suggests a proinflammatory imbalance in ND-IDDM patients and this may play an important role in beta-cell loss [9].
###end p 6
###begin p 7
###xml 134 136 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 309 310 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 312 314 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 421 423 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
The proinflammatory cytokines IL-1, IL-2, and TNF-alpha may play important roles alone or in combination in the pathogenesis of IDDM [10]. IL-1beta and TNF-alpha levels can be used as indicators of continuing autoimmune aggression against beta cells before the development of extensive beta-cell destruction [8, 11]. Circulating IL-6, TNF-alpha, and CRP have been also determined as markers of the inflammatory response [12].
###end p 7
###begin p 8
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 398 399 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 401 403 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 417 419 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 436 437 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 439 440 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 531 532 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 534 535 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 552 560 <span type="species:ncbi:9606">children</span>
There is little and conflicting information regarding circulating levels and in vitro production of cytokines in diabetes. Several studies have found an increase in serum IL-6 concentrations [4, 13]; however some studies reported no difference [14] or even decreased [15] IL-6 levels. Results regarding levels and/or production of TNF-alpha have been inconclusive and are reported to be increased [4, 16], decreased [15], or unchanged [8, 9] as well. The effects of glycemic control on cytokines are consistent in several studies [4, 7], especially in children. The circulating levels of these cytokines in the development of type 1 DM have no conclusion in different studies.
###end p 8
###begin p 9
###xml 104 112 <span type="species:ncbi:9606">children</span>
The aim of this study was to investigate serum concentrations of IL-1beta, IL-2, IL-6, and TNF-alpha in children IDDM.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin p 11
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 37 45 <span type="species:ncbi:9606">children</span>
###xml 81 89 <span type="species:ncbi:9606">Children</span>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
The study population consisted of 27 children with IDDM and 25 healthy controls. Children with IDDM were divided into three subgroups: (1) previously diagnosed patients (long standing IDDM) (n : 15), (2) newly diagnosed patients with diabetic ketoacidosis (before treatment) (n : 12), and (3) newly diagnosed patients with diabetic ketoacidosis (after treatment) (n : 12).
###end p 11
###begin p 12
###xml 611 618 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 99 107 <span type="species:ncbi:9606">children</span>
###xml 346 354 <span type="species:ncbi:9606">patients</span>
###xml 429 437 <span type="species:ncbi:9606">children</span>
After the written informed parental consents were obtained, we collected the serum samples from 27 children with IDDM (12 females, 15 males) at our pediatric diabetes clinics. Subjects with any diabetic complications such as nephropathy, neuropathy or retinopathy, acute or chronic diseases, or oral medication were excluded from this study. All patients were treated with daily regular doses of insulin (1 IU/kg/d). Twenty five children without diabetes (11 females, 14 males) were recruited for the control group. The age range of the subjects was 4-17 years. Baseline features of the groups are presented in Table 1.
###end p 12
###begin p 13
The background information of subjects such as age, gender, body weight, body height, daily dose of insulin injection, and disease duration were recorded. Disease duration was defined in this study as the day of initial diagnosis of diabetes to the day of blood collection. Blood samples (five milliliters) were collected using standard venipuncture technique between 9:00 and 11:00 AM. Serum samples were separeted immedately after centrifugation at +4degreesC, 4000 rpm for 10 minutes and stored at -20degreesC until analysis.
###end p 13
###begin p 14
Percent concentration of HbA1c in whole blood was measured with Roche diagnostics HbA1c kits with autoanalyzer (Cobas Integra 800 Autoanalyzer, Roche Diagnostics, Germany). This assay based on the immunoturbidometric determination of the stable glucose adducct to N-terminal group of the haemaoglobin beta chain. Serum concentrations of cytokines such as IL-1beta, IL-2, IL-6, and TNF-alpha were measured using commercially available enzyme-linked immunosorbent assay kits (ELISA kits, Biosource Int, Calif). All of the serum samples were analyzed in one assay in duplicate with intra- and interassay < 10%. (IL-1beta sensitivity < 2 pg/mL, interassay %4.6, intrassay %3.4; IL-2 sensitivity < 0.1 U/mL, interassay %7.5, intrassay %5.7; IL-6 sensitivity < 2 pg/mL, interassay %8.0, intrassay %6.0; and TNF-alpha sensitivity < 3 pg/mL, interassay %9.9, intrassay %5.2.)
###end p 14
###begin title 15
STATISTICS
###end title 15
###begin p 16
###xml 109 110 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 133 134 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 224 225 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 924 925 920 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 379 387 <span type="species:ncbi:9606">children</span>
###xml 834 842 <span type="species:ncbi:9606">children</span>
Data is presented as mean+/-SD. Comparison of variables was performed with the general linear model, student t test, or Mann-Whitney U test when necessary. Case-control differences in nominal data were evaluated with the chi2 test. Statistical analysis was performed using SPSS for Windows (SPSS Advanced 7.5, SPSS, Chicago, Ill, 1997). The comparisons of serum cytokine between children with diabetes and healthy were determined by multivariate analysis of variance (MANOVA). A simple linear correlation analysis was processed by Pearson's method to assess the correlation between age, BMI, HbA1c, and cytokine in healthy and diabetic subjects, respectively. A forward stepwise multiple linear regression analysis was done to identify the influence of multiple variables, including age, diabetes, gender, BMI, HbA1c, and cytokine in children with diabetes and healthy, respectively. Statistical significance was assumed at P < .05.
###end p 16
###begin title 17
RESULTS
###end title 17
###begin p 18
###xml 407 408 399 400 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</chem-struct>
###xml 519 520 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 525 526 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 492 500 <span type="species:ncbi:9606">children</span>
In this study groups mean age and age range were as follows: control group (10.5 +/- 1.0 year) (8-13 year), LS-IDDDM group (10.6 +/- 2.1 year) (7-15 year), and ND-IDDM group (9.5 +/- 1.6 year) (6-13 year). Mean diabetes duration was 2.9 +/- 1.0 year in LS-IDDM groups. The present study was carried out to investigate serum concentrations of body mass index (BMI), HbA1c, microalbuminuria, antistreptolysin O (ASO), C-reactive protein (CRP), white blood cell (WBC), and IL-6 and TNF-alpha in children with IDDM (Tables 1 and 2).
###end p 18
###begin p 19
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
As shown in Table 1, the level of glucose were significantly higher in control groups compared to LS-IDDM and ND-IDDM groups in this study (P < .01, P < .001). Hba1c levels especially were significantly higher than control group compared to LS-IDDM and ND-IDDM groups. Also there was a significantly increase in the level of microalbuminuria in diabetic groups and the positive correlation was showed between Hba1c level and microalbuminuria in diabetic groups (r : 0.71, P < .01 and r : 0.678, P < .01).
###end p 19
###begin p 20
###xml 147 148 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 153 154 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 244 245 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 255 256 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 310 311 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 321 322 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 440 441 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 451 452 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 501 502 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 512 513 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In all stages of diabetes higher levels of IL-1beta and TNF-alpha and lower levels of IL-2 and IL-6 were detected. The results are shown in Tables 1 and 2. There was a significantly positive correlation between the levels of IL-1beta and IL-6 (r : 0.534, P < .05) and between the levels of IL-6 and TNF-alpha (r : 0.565, P < .05) in LS-IDDM. Also, in ND-IDDM group, a significantly positive correlation between the levels of IL-2 and IL-6 (r : 0,698, P < .01) and between the levels of IL-2 and IL-6 (r : 0.705, P < .01) was showed.
###end p 20
###begin title 21
DISCUSSION
###end title 21
###begin p 22
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 221 223 218 220 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</chem-struct>
###xml 225 226 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 298 299 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 319 320 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 322 324 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 541 543 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 545 547 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 601 603 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 605 607 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 609 611 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 733 734 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1002 1004 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1006 1008 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1145 1147 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1254 1256 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 311 317 <span type="species:ncbi:9606">humans</span>
Chemokines play a central role in inflammatory processes by regulating leukocyte migration into sites of tissue damage [4]. Cytokines have been proposed as inducers of beta-cell damage in human IDDM via the generation of NO [5]. The proinflammatory cytokines IL-6 and TNF-alpha are common to both TH subsets in humans [4, 10]. TNF-alpha and IL-6-mediated damage to micro- and macrovascular tissues, altered insulin secretion through direct or through stimulation of free fatty acid production, and altered glucose homeostasis are suggested [17, 18]. IL-6 and TNF-alpha are adipocyte-secreted factors [16, 17, 19]. TNF-alpha injection induces an increase in the concentration of plasma triglyceride and very low density lipoproteins [4]. The proinflammatory cytokine production is elevated in diabetes and in cases of elevated lipids. Diabetes induced abnormalities in fatty acid metabolism have the potential to influence macrophage cytokine release inducing upregulation of proinflammatory cytokines [20, 21]. The proinflammatory cytokines IL-1, IL-2, and TNF-alpha may play important roles alone or in combination in the pathogenesis of IDDM [10]. Circulating IL-6, TNF-alpha, and CRP have been also determined as markers of the inflammatory response [12].
###end p 22
###begin p 23
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 544 545 544 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1051 1059 <span type="species:ncbi:9606">patients</span>
The IL-2 system which involves IL-2 production, IL-2 receptor expression, and response to IL-2 is associated with autoimmune phenomena. Immunological abnormalities including autoimmune phenomena are believed to contribute to the pathogenesis of IDDM. In IDDM, IL-2 production by CD4-positive T lymphocytes within the IL-2 system is thought to be selectively defective [22]. Deficient production of IL-2 has been reported in IDDM, but its cause has not been elucidated [23, 24]. T lymphocytes are implicated in the pathogenesis of IDDM. IL-2-a TH1 lymphocyte-derived cytokine-is at present considered to play an important role in the etiopathogenesis of IDDM. Activated T lymphocytes expressing IL-2 receptors are found at increased levels in the peripheral blood in the prediabetic period, at diagnosis and for several months after the onset of the disease, but their role in the pathogenesis of the disease is not known [25]. In previous studies with variable outcomes, IL-2 levels were found to be increased, decreased [22, 26, 27], or unchanged in patients with IDDM. These differences can be a result of different metabolic status or/and a different stage of the autoimmune process [28].
###end p 23
###begin p 24
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 176 184 <span type="species:ncbi:9606">children</span>
###xml 525 533 <span type="species:ncbi:9606">patients</span>
IL-2 receptors are released in the circulation in response to antigenic or mitogenic stimulation of T lymphocytes. Abnormal serum IL-2 receptor levels have been found in young children with IDDM and prediabetes. This phenomenon is acquired close to disease onset and is unlikely to be an early marker of IDDM [29]. Soluble IL-2 receptor (sIL-2R) levels reflect mononuclear cell activation and are elevated in a variety of autoimmune, neoplastic, and infectious conditions. Several investigators have studied sIL-2R levels in patients with IDDM, but results (low and elevated) have been conflicting [30].
###end p 24
###begin p 25
###xml 273 280 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
The present study suggests the involvement of IL-2 in the pathogenesis of IDDM. In our study IL-2 levels decreased notably in all groups. Especially in patients monitored for a long time with a diagnosis of IDDM a significant decrease in IL-2 levels is a striking finding (Table 2). These results confirm the presence of an imbalanced cellular immune response in IDDM patients and demonstrate that the IL-2 deficiency is already present at the diagnosis [27]. The decreased IL-2 synthesis is specific for IDDM, not explainable solely as a consequence of poor metabolic control, and thus, might be involved in the pathogenesis of the disease [31]. The low levels of IL-2 might be explained by an abnormal consumption or by the presence of increased sIL-2R levels or by a serum factor which interferes with IL-2 production [32]. These results suggest that in recent onset IDDM, IL-2-receptor-positive circulating T cells require an IL-2 supply [24].
###end p 25
###begin p 26
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 564 571 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 943 944 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 313 321 <span type="species:ncbi:9606">children</span>
###xml 633 641 <span type="species:ncbi:9606">children</span>
###xml 770 778 <span type="species:ncbi:9606">patients</span>
###xml 990 998 <span type="species:ncbi:9606">patients</span>
IL-6 might play a significant role in IDDM etiopathogenesis [32]. Diabetic patients have elevated blood levels of IL-6, which is known to increase the inflammation and the development of vascular disease and atherosclerosis [33]. IL-6 levels were found to be decreased statistically significantly in any group of children with IDDM especially in newly diagnosed cases when compared with healthy controls. Even a statistically significant difference was revealed between IL-6 values related to newly diagnosed cases and those found during the posttreatment period (Table 2). In our study IL-6 levels did not reach to those of healthy children even though they rised from their lowest values in newly diagnosed cases to posttreatment values, and increased further in IDDM patients monitored for a long-term. However in some studies IL-6 levels were found to be higher in newly diagnosed cases when compared with those monitored for a long time [4]. The reports of IL-6 abnormal production in patients with IDDM are rare [25].
###end p 26
###begin p 27
###xml 314 315 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 429 430 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 522 523 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
TNF-alpha remained at its highest levels in all chronic cases. Even a statistically significant difference existed between newly diagnosed cases and posttreatment group. Higher levels of TNF-alpha found in every stage of the disease indicate the persistence of activation of systemic immune inflammatory response [4]. In our cases levels of TNF-alpha increased parallel with the chronicity of the disease. However Erbagci et al [4] found higher levels in newly diagnosed cases. In contrast with our findings, Netea et al [9] revealed that TNF-alpha concentrations did not change in newly diagnosed cases and chronic IDDM patients.
###end p 27
###begin p 28
###xml 455 456 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
In this study serum ASO, CRP, WBC, and proinflammatory cytokine concentrations (IL-1beta, IL-6) indicated a state of chronic inflammation in all patients with IDDM. Levels of IL-1beta and IL-6 in all DM groups were detected to be significantly different from those of healthy controls. TNF-alpha levels in all DM groups were found to be significantly different from both control and all other groups including posttreatment groups. However Erbagci et al [4] revealed that CRP, IL-6, and TNF-alpha levels were not different from those of control group.
###end p 28
###begin p 29
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
Changes in interleukin levels are not limited to early stages of the disease but it persist in advanced stages. In some studies these changes were found to be restricted to only the first stage of the disease [31].
###end p 29
###begin p 30
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
In this study we compared patients in different stages of diabetes among themselves and with healthy control group. Our data about elevated serum IL-1beta, TNF-alpha and decreased IL-2, IL-6 levels in newly diagnosed IDDM patients in comparison with longer standing cases supports an activation of systemic inflammatory process during early phases of IDDM which may be indicative of an ongoing beta-cell destruction. Persistence of significant difference between the cases with IDDM monitored for a long time and controls in terms of IL-1beta, IL-2, IL-6, and TNF-alpha supports continuous activation during the late stages of diabetes.
###end p 30
###begin article-title 31
Multiple immuno-regulatory defects in type-1 diabetes
###end article-title 31
###begin article-title 32
###xml 20 28 <span type="species:ncbi:9606">children</span>
Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes
###end article-title 32
###begin article-title 33
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Cytokine overproduction in healthy first degree relatives of patients with IDDM
###end article-title 33
###begin article-title 34
###xml 29 37 <span type="species:ncbi:9606">children</span>
###xml 98 106 <span type="species:ncbi:9606">children</span>
Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children
###end article-title 34
###begin article-title 35
###xml 19 24 <span type="species:ncbi:9606">human</span>
Cytokines suppress human islet function irrespective of their effects on nitric oxide generation
###end article-title 35
###begin article-title 36
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation
###end article-title 36
###begin article-title 37
###xml 151 159 <span type="species:ncbi:9606">patients</span>
Decreased secretion of Th2 cytokines precedes Up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus
###end article-title 37
###begin article-title 38
###xml 122 130 <span type="species:ncbi:9606">children</span>
Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM
###end article-title 38
###begin article-title 39
Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals
###end article-title 39
###begin article-title 40
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Serum IL-1, IL-2, TNF-alpha and INF-gamma levels of patients with type 1 diabetes mellitus and their siblings
###end article-title 40
###begin article-title 41
Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus
###end article-title 41
###begin article-title 42
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration
###end article-title 42
###begin article-title 43
Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications
###end article-title 43
###begin article-title 44
###xml 67 75 <span type="species:ncbi:9606">patients</span>
TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide
###end article-title 44
###begin article-title 45
###xml 34 39 <span type="species:ncbi:9606">women</span>
Cytokine secretion is impaired in women with diabetes mellitus
###end article-title 45
###begin article-title 46
Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes
###end article-title 46
###begin article-title 47
TNF-alpha and insulin resistance: summary and future prospects
###end article-title 47
###begin article-title 48
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study
###end article-title 48
###begin article-title 49
###xml 69 74 <span type="species:ncbi:9606">human</span>
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes
###end article-title 49
###begin article-title 50
###xml 163 167 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats
###end article-title 50
###begin article-title 51
RAGE: a novel cellular receptor for advanced glycation end products
###end article-title 51
###begin article-title 52
###xml 41 49 <span type="species:ncbi:9606">children</span>
Imbalance of the interleukin 2 system in children with IDDM
###end article-title 52
###begin article-title 53
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Acquired defect in interleukin-2 production in patients with type I diabetes mellitus
###end article-title 53
###begin article-title 54
###xml 56 64 <span type="species:ncbi:9606">children</span>
Alterations of in vitro interleukin 1 and 2 in diabetic children
###end article-title 54
###begin article-title 55
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Expression levels of IL-6 mRNA in PBMNCs from patients with IDDM, NIDDM and normals by RT-PCR procedure
###end article-title 55
###begin article-title 56
Low interleukin-2 synthesis by type 1 diabetics is regulated at the pretranslational level
###end article-title 56
###begin article-title 57
###xml 66 74 <span type="species:ncbi:9606">children</span>
Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes
###end article-title 57
###begin article-title 58
In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects
###end article-title 58
###begin article-title 59
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Low interleukin-2 receptor levels in serum of patients with insulin-dependent diabetes
###end article-title 59
###begin article-title 60
###xml 41 49 <span type="species:ncbi:9606">children</span>
Soluble interleukin 2 receptor levels in children with type I insulin-dependent diabetes mellitus
###end article-title 60
###begin article-title 61
Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus
###end article-title 61
###begin article-title 62
###xml 45 53 <span type="species:ncbi:9606">children</span>
Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus
###end article-title 62
###begin article-title 63
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes
###end article-title 63
###begin title 64
Figures and Tables
###end title 64
###begin p 65
Baseline characteristics of the study groups (mean +/- SD).
###end p 65
###begin p 66
Specific parameters of the study groups (mean +/- SD).
###end p 66

